SPIRONOLACTON- RATIOPHARM 50MG tablett أستونيا - الإستونية - Ravimiamet

spironolacton- ratiopharm 50mg tablett

ratiopharm gmbh - spironolaktoon - tablett - 50mg 50tk; 50mg 20tk

VEROSPIRON tablett أستونيا - الإستونية - Ravimiamet

verospiron tablett

gedeon richter plc. - spironolaktoon - tablett - 25mg 20tk

VEROSPIRON kõvakapsel أستونيا - الإستونية - Ravimiamet

verospiron kõvakapsel

gedeon richter plc. - spironolaktoon - kõvakapsel - 50mg 30tk

SPIROGAMMA 50 tablett أستونيا - الإستونية - Ravimiamet

spirogamma 50 tablett

woerwag pharma gmbh & co. kg - spironolaktoon - tablett - 50mg 20tk; 50mg 50tk

SPIRIX tablett أستونيا - الإستونية - Ravimiamet

spirix tablett

orifarm healthcare a/s - spironolaktoon - tablett - 50mg 20tk

Qaialdo الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolaktoon - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.

SPIRIX tablett أستونيا - الإستونية - Ravimiamet

spirix tablett

orifarm healthcare a/s - spironolaktoon - tablett - 25mg 20tk; 25mg 100tk; 25mg 60tk

SPIROCOMP-RATIOPHARM tablett أستونيا - الإستونية - Ravimiamet

spirocomp-ratiopharm tablett

ratiopharm gmbh - furosemiid+spironolaktoon - tablett - 20mg+50mg 100tk

SPIRO COMP.-RATIOPHARM õhukese polümeerikattega tablett أستونيا - الإستونية - Ravimiamet

spiro comp.-ratiopharm õhukese polümeerikattega tablett

merckle gmbh - furosemiid+spironolaktoon - õhukese polümeerikattega tablett - 20mg+50mg 100tk

Lysodren الاتحاد الأوروبي - الإستونية - EMA (European Medicines Agency)

lysodren

hra pharma rare diseases - mitotane - neerupealiste korteede neoplasmid - antineoplastilised ained - arenenud (retsidiivne, metastaatiline või retsidiivne) neerupealise koore kartsinoom sümptomaatiline ravi. mõju lysodren mitte-funktsionaalne neerupealise koore kartsinoom ei ole tuvastatud.